Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting
Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older
New Therapies Could Benefit Patients With Difficult Cancers
Radiation Improves Survival In Advanced Prostate Cancer
Survivors With Gene Variant At More Risk For Heart Disease
ASCO, FDA Website To Help Demystify Expanded Access
NCI Trials Listed
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe









